SyncThink Expands IP With Patent for Content Adaptation to Subject’s Attention Using Eye Tracking

SyncThink, a world leader in neurotechnology and brain health analytics and creators of the award-winning EYE-SYNC brain health assessment tool, has been granted patent US 15/967,440 by the U.S. Patent and Trade Office. This patent, the 14th for SyncThink, allows the company to assess a person’s attention, measured through online eye tracking, to change content and the rate of content delivery in accordance to the person’s attention level. The patent will broaden the application of EYE-SYNC technology through the use of virtual reality (VR), augmented reality (AR), and mixed reality (XR) environments.
 
“Eye tracking is a foundational technology that has the potential to dramatically improve the way we experience content. By using eye tracking analytics to precisely measure attention the user will automatically receive the right content at the pace optimized for them— this benefits both the creator and the receiver” said Laura Yecies, CEO of SyncThink.  
 
SyncThink currently maintains 12 additional U.S. patents and one European patent in the eye tracking analytics and the VR hardware space, ranging from techniques for improving cognition and motor timing, to eye tracking headset design for visual impairment testing in the assessment of brain health. It also received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) this year recognizing that EYE-SYNC has the potential to solve an important unmet need for providing objective measurements to aid in the assessment of concussion.
 
“People naturally manage and react to attention when interacting with each other. Our devices could be so much more responsive and respectful if given access to the same cognitive cues,” said Daniel Beeler, chief technology officer of SyncThink.
 
The ability to personalize content delivery and adapt it to changing attention will revolutionize the way we interact with previously inert content. Just as we adapt our conversations based on the receiving person’s interest and capabilities, so content becomes animated and responsive to a person’s attention.
 
This new patent will allow SyncThink to advance the evolution of their proprietary technology to capture more intuitive and realistic interactions involving human attention. By doing so, unique content can be created and delivered to measure how information is consumed, and changed based on the types of interactions occurring in order to identify and optimize different states of attention. 
 
SyncThink has previously announced granted patents for dynamic content creation based on eye gaze attention analysis, and recently partnered with XR and spatial computing leader Magic Leap to develop a next gen eye tracking platform for future brain health initiatives. 

SyncThink is on a mission to provide objective measurements for brain health and empower people to maximize their health and performance. SyncThink develops eye tracking technology and analytics, in a VR environment, that assist medical professionals in assessing brain health, monitoring recovery and optimizing performance. With more than 30 published peer-reviewed papers and 14 granted patents, the SyncThink platform uses a series of 60-second assessments to objectively measure eye movements to identify impairments and offers multiple modalities to train dynamic vision. FDA-cleared for detecting eye tracking impairment and used by medical centers such as Stanford and Massachusetts General, the U.S. military, and more than 20 top universities, SyncThink is transforming assessment, recovery, and performance for life and sport.